S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Virios Therapeutics (VIRI) SEC Filings & 10K Form

$0.44
-0.01 (-2.21%)
(As of 04/18/2024 ET)

Recent Virios Therapeutics SEC Filings

DateFilerForm TypeView
03/01/2024
8:10 AM
Virios Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
8:25 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
11:43 AM
Gendreau Roger Michael (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:47 AM
Grosswald Ralph (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:51 AM
Virios Therapeutics (Issuer)
Walsh Angela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:54 AM
De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:40 AM
Duncan Gregory Scott (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:21 PM
Virios Therapeutics (Filer)
Form DEFA14A
02/13/2024
5:01 PM
Corday Brian David (Filed by)
Virios Therapeutics (Subject)
Form SC 13G/A
02/02/2024
3:31 PM
Virios Therapeutics (Filer)
Form DEF 14A
02/02/2024
3:31 PM
Virios Therapeutics (Filer)
Form DEF 14A
01/22/2024
8:33 AM
Virios Therapeutics (Filer)
Form PRE 14A
01/03/2024
6:05 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:10 AM
Virios Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
6:20 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:29 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
6:05 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
6:16 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
6:05 AM
Duncan Gregory Scott (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
7:22 AM
Virios Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:15 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:15 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
6:15 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:25 PM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:12 PM
Virios Therapeutics (Filer)
Form 424B5
06/20/2023
3:35 PM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
12:56 PM
Virios Therapeutics (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
12:58 PM
Burch Richard Alan (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
1:01 PM
Thomas John C (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
1:03 PM
De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
1:06 PM
Keefer David R (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
12:53 PM
Pridgen William (Reporting)
Virios Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:41 PM
Corday Brian David (Filed by)
Virios Therapeutics (Subject)
Form SC 13G/A
05/25/2023
7:30 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
12:37 PM
Corday Brian David (Filed by)
Virios Therapeutics (Subject)
Form SC 13G/A
05/12/2023
7:34 AM
Virios Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2023
6:20 AM
Virios Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2023
8:07 AM
Virios Therapeutics (Filer)
Form ARS
04/27/2023
6:31 AM
Virios Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VIRI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners